Evoke Pharma, Inc. (EVOK) Financials
EVOK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 7.1 million | 9.6 million |
| 2023-09-30 | 7.9 million | 8.7 million |
| 2023-06-30 | 9.0 million | 8.4 million |
| 2023-03-31 | 10.0 million | 7.9 million |
EVOK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.1 million | 281639 |
| 2023-09-30 | -1.0 million | 281758 |
| 2023-06-30 | -1.2 million | 280140 |
| 2023-03-31 | -1.6 million | 284572 |
EVOK Net Income
No data available :(
EVOK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 4.7 million | - | - |
| 2023-09-30 | 6.0 million | - | 13370 |
| 2023-06-30 | 7.0 million | - | 52842 |
| 2023-03-31 | 8.2 million | - | 91397 |
EVOK Shares Outstanding
EVOK Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 22560 | 3.5 million | - |
| 2023-09-30 | - | - | 3.1 million | - |
| 2023-06-30 | - | 92357 | 2.8 million | - |
| 2023-03-31 | - | 66990 | 2.8 million | - |
EVOK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.7 million | 59024 |
| 2023-09-30 | 1.6 million | 34908 |
| 2023-06-30 | 1.1 million | 57357 |
| 2023-03-31 | 810408 | 50591 |
EVOK
Price: $0.46
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.33 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 13353
Ebitda: -3.7 millionMarket Capitalization: 5.0 million